Bio Essence Corp. Files 2024 10-K
Ticker: BIOE · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1723059
| Field | Detail |
|---|---|
| Company | Bio Essence CORP (BIOE) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Bio Essence Corp. filed its 2024 10-K, showing no 12(b) registered securities but common stock under 12(g).
AI Summary
Bio Essence Corp. filed its 2024 annual report (10-K) on March 28, 2025. The company, incorporated in California and headquartered in Irvine, operates in the Pharmaceutical Preparations sector. Its principal executive offices are located at 2955 Main Street, Suite 300, Irvine, CA 92618, with a business phone number of 888-816-1494. The company's common stock is registered under Section 12(g) of the Exchange Act, but no securities are registered under Section 12(b).
Why It Matters
This filing provides a comprehensive overview of Bio Essence Corp.'s financial performance and business operations for the fiscal year ended December 31, 2024, which is crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The provided text is a standard 10-K filing header and does not contain specific financial performance data or forward-looking statements that would indicate a high risk.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- March 28, 2025 — Filing Date (The date the 10-K was submitted to the SEC.)
Key Players & Entities
- Bio Essence Corp. (company) — Registrant
- 2024 (date) — Fiscal year end
- March 28, 2025 (date) — Filing date
- California (location) — State of incorporation
- Irvine (location) — City of principal executive offices
- 2955 Main Street, Suite 300, Irvine CA 92618 (address) — Principal executive offices
- 888-816-1494 (phone_number) — Business phone number
- Common Stock, $0.0001 par value per share (security) — Registered under Section 12(g)
FAQ
What is the primary business of Bio Essence Corp.?
Bio Essence Corp. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
Where are Bio Essence Corp.'s principal executive offices located?
The principal executive offices of Bio Essence Corp. are located at 2955 Main Street, Suite 300, Irvine, CA 92618.
Are any of Bio Essence Corp.'s securities registered under Section 12(b) of the Exchange Act?
No, the filing explicitly states that no securities are registered under Section 12(b) of the Exchange Act.
What type of securities are registered under Section 12(g) for Bio Essence Corp.?
The company's Common Stock, with a par value of $0.0001 per share, is registered under Section 12(g) of the Exchange Act.
When was the 10-K filing for the fiscal year 2024 submitted?
The 10-K filing for the fiscal year ended December 31, 2024, was filed as of March 28, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding Bio Essence Corp (BIOE).